Civil society monitoring of harm reduction in Europe 2021. Data report

R. RIGONI ; T. TAMMI ; D. VAN DER GOUWE ; J. MOURA ; K. PRINS-SCHIFFER | 2022
Rapport

ENGLISH: The main aim and purpose of C-EHRN monitoring activities is to improve knowledge and information and complement existing data and monitoring efforts in Europe in specific areas of harm reduction based on the perspective of civil societ[...]

Plus d'info

Ajouter à la sélection

Lien externe

Drug consumption rooms in Europe: Operational overview

Correlation - European Harm Reduction Network ; J. MOURA ; L. DARRAGH ; R. PEREZ GAYO ; I. JEZIORSKA ; K. SCHIFFER | 2023
Rapport

The study aims to provide an overview of the range, scope and structure of care services for people who use drugs currently provided by drug consumption rooms in Europe. To this end, the study: - describes the operational characteristics, capac[...]

Plus d'info

Ajouter à la sélection

Lien externe

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023

M. MATICIC ; J. CERNOSA ; C. LOBODA ; J. TAMSE ; R. RIGONI ; E. DUFFELL ; I. INDAVE ; R. ZIMMERMANN ; L. DARRAGH ; J. MOURA ; A. LEICHT ; T. WINDELINCKX ; M. JAUFFRET-ROUSTIDE ; K. SCHIFFER ; T. TAMMI | 2024
Dans Harm Reduction Journal (Vol.21, 2024) Article : Périodique

BACKGROUND: With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the majority[...]

Plus d'info

Ajouter à la sélection

Lien externe